CVE:NSCI Nanalysis Scientific (NSCI) Stock Price, News & Analysis C$0.26 -0.01 (-1.92%) As of 03:25 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesBuy This Stock About Nanalysis Scientific Stock (CVE:NSCI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nanalysis Scientific alerts:Sign Up Key Stats Today's RangeC$0.26▼C$0.2650-Day RangeC$0.25▼C$0.3352-Week RangeC$0.25▼C$0.47Volume27,302 shsAverage Volume58,312 shsMarket CapitalizationC$28.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.Read More… Receive NSCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanalysis Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address NSCI Stock News HeadlinesNanalysis Scientific Corp.: Nanalysis Announces First Quarter 2025 ResultsMay 29, 2025 | finanznachrichten.deNanalysis Scientific Corp. (NSCIF) Q1 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.June 3, 2025 | True Market Insiders (Ad)Nanalysis Announces First Quarter 2025 Conference CallMay 15, 2025 | uk.finance.yahoo.comNanalysis Scientific Corp.: Nanalysis Announces Fourth Quarter and Full Year 2024 ResultsMay 3, 2025 | finanznachrichten.deEarnings call transcript: Nanalysis Scientific Q4 2024 revenue beats forecastApril 26, 2025 | investing.comNanalysis Scientific With President & CEO, Sean KrakiwskyApril 26, 2025 | msn.comNanalysis Scientific Corp. (NSCIF) Q4 2024 Earnings Call TranscriptApril 25, 2025 | seekingalpha.comSee More Headlines NSCI Stock Analysis - Frequently Asked Questions How have NSCI shares performed this year? Nanalysis Scientific's stock was trading at C$0.32 at the beginning of the year. Since then, NSCI shares have decreased by 20.3% and is now trading at C$0.26. View the best growth stocks for 2025 here. How do I buy shares of Nanalysis Scientific? Shares of NSCI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Nanalysis Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nanalysis Scientific investors own include Lightwave Logic (LWLG), Air Canada (AC), CloudMD Software & Services (DOC), NioCorp Developments (NIOBF), Tilray (TLRY), Achieve Life Sciences (ACHV) and Alamos Gold (AGI). Industry, Sector and Symbol Stock ExchangeCVE SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryN/A Current SymbolCVE:NSCI CIKN/A Webwww.nanalysis.com Phone403-769-9499FaxN/AEmployees249Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.12) Trailing P/E RatioN/A Forward P/E Ratio14.03 P/E GrowthN/ANet Income-C$12.93 million Net Margins-32.75% Pretax MarginN/A Return on Equity-38.02% Return on Assets-7.55% Debt Debt-to-Equity Ratio71.72 Current Ratio1.42 Quick Ratio1.11 Sales & Book Value Annual SalesC$39.47 million Price / Sales0.73 Cash FlowC$0.03 per share Price / Cash Flow8.93 Book ValueC$0.21 per share Price / Book1.21Miscellaneous Outstanding Shares113,060,000Free FloatN/AMarket CapC$28.83 million OptionableNot Optionable Beta0.72 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (CVE:NSCI) was last updated on 6/3/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanalysis Scientific Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanalysis Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.